Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research – GlobeNewswire (press release)
GlobeNewswire (press release) |
Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research
GlobeNewswire (press release) Intrommune Therapeutics is pleased to announce the launch of a crowdfunding campaign on the Netcapital platform. This campaign supports the next steps of development for INT-301, an oral mucosal immunotherapy (OMIT) product for the long-term treatment … |
